Technology | Advanced Visualization | February 08, 2019

Advanced visualization software includes new applications for MRI, cardiology and endoscopy

Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D


February 7, 2019 — Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15 in Orlando, Fla. The latest Synapse 3D Advanced Visualization software introduces five new applications, in addition to its current 50 clinical applications, that will be available for demonstration.

An enterprise-wide solution designed to quickly perform advanced visualization workflows and access 3-D rendered images, Synapse 3D boasts a total of 55 advanced applications, including five newly launched tools:

  • Breast Analyzer MR — A multi-faceted application that analyzes breast tumors in magnetic resonance imaging (MRI) and generates Breast Imaging-Reporting and Data System (BI-RADS) reports. It includes kinetic curves for wash-in and wash-out, and subtraction of pre- and post-contrast. The tool also performs a variety of measurements including distance from the nipple, distance from the skin, distance from the chest wall and tumor volume.
  • Delayed Enhancement MR — Designed with input from cardiologists, this application analyzes myocardial viability, provides delayed enhancement area and volume measurements, and displays the enhanced area overlaid in the bulls-eye map.
  • Endoscopic Simulator — With simulation now a key tool in training of physicians, this application was designed specifically for laparoscopic surgery simulation. It simulates inflation of the abdomen, port placement and positioning. The tool also offers the capability to automatically segment vessels, skin, bone, pancreas, spleen and tumors.
  • Intravoxel Incoherent Motion (IVIM) MR — The tool uses diffusion-weighted images to provide quantitative data from tissue microcapillary perfusion. It also automatically displays an ADC map, eADC map, D map, D* map and f map.
  • Prostate Viewer MR — A robust application to support prostate cancer diagnosis, this tool analyzes prostate gland tumors and generates Prostate Imaging-Reporting and Data System (PI-RADS) reports. It measures both diameter and volume of the prostate gland and lesions. It also features an array of viewing tools for comparative observation of multiple series, T2, ADC, DWI, DCE and time intensity curves.

In addition to these new applications, Synapse 3D delivers a comprehensive suite of applications consisting of general-use and specialty options for advanced image visualization and analysis. The software features Image Intelligence recognition technology that helps optimize processing capabilities, providing increased confidence in image assessment for providers. Designed with extensive clinical input, Synapse 3D incorporates intuitive, logical workflows that guide users to efficient and accurate results that can lead to improved patient outcomes.

For more information: www.fujimed.com


Related Content

News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | HIMSS

March 3, 2026 — MedDream will present its cloud-native, AI-ready universal DICOM viewer in the Amazon Web Services (AWS) ...

Time March 03, 2026
arrow
News

Feb. 26, 2026 — GE HealthCare and UCSF Health have announced a 10-year Care Alliance collaboration focused on ...

Time March 02, 2026
arrow
News | Remote Viewing Systems

Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet ...

Time February 27, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | Contrast Media

Feb. 23, 2026 — Bracco, a global leader in diagnostic imaging, recently announced that the U.S. Food and Drug ...

Time February 24, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
Subscribe Now